ID

23991

Description

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin; ODM derived from: https://clinicaltrials.gov/show/NCT00519480

Lien

https://clinicaltrials.gov/show/NCT00519480

Mots-clés

  1. 20/07/2017 20/07/2017 -
Téléchargé le

20 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes Mellitus NCT00519480

Eligibility Type 2 Diabetes Mellitus NCT00519480

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes for at least three months prior to study
Description

ID.1

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
diabetes treated with metformin only
Description

ID.2

Type de données

boolean

Alias
UMLS CUI [1]
C0025598
give consent and sign an informed consent form.
Description

ID.3

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
agree to follow specific requirements of birth control during participation.
Description

ID.4

Type de données

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type i diabetes.
Description

ID.5

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
treatment with insulin within 3 months prior to screening
Description

ID.6

Type de données

boolean

Alias
UMLS CUI [1]
C0745343
history of diabetic ketoacidosis or lactic acidosis
Description

ID.7

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001125
UMLS CUI [1,2]
C0011880
allergy or sensitivity to metformin or similar drugs or any medical conditions which prohibit metformin use
Description

ID.8

Type de données

boolean

Alias
UMLS CUI [1]
C0571648
excessive blood donation 56 days before the start of the study
Description

ID.9

Type de données

boolean

Alias
UMLS CUI [1]
C0005794
urinary tract or bladder infections within four weeks of study start
Description

ID.10

Type de données

boolean

Alias
UMLS CUI [1,1]
C0042029
UMLS CUI [1,2]
C0600041
alcohol abuse or illicit drug use within 12 months of study start
Description

ID.11

Type de données

boolean

Alias
UMLS CUI [1,1]
C0085762
UMLS CUI [1,2]
C0086190
receiving other investigational drugs or participating in other research trials within 30 of the study start
Description

ID.12

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements with 7-14 days of study start
Description

ID.13

Type de données

boolean

Alias
UMLS CUI [1,1]
C0033081
UMLS CUI [1,2]
C0013231
live alone without regular, daily interactions with someone who can be an emergency contact
Description

ID.14

Type de données

boolean

Alias
UMLS CUI [1,1]
C0260794
UMLS CUI [1,2]
C1552023

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00519480

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosed with type 2 diabetes for at least three months prior to study
boolean
C0011860 (UMLS CUI [1])
ID.2
Item
diabetes treated with metformin only
boolean
C0025598 (UMLS CUI [1])
ID.3
Item
give consent and sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
ID.4
Item
agree to follow specific requirements of birth control during participation.
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.5
Item
type i diabetes.
boolean
C0011854 (UMLS CUI [1])
ID.6
Item
treatment with insulin within 3 months prior to screening
boolean
C0745343 (UMLS CUI [1])
ID.7
Item
history of diabetic ketoacidosis or lactic acidosis
boolean
C0001125 (UMLS CUI [1,1])
C0011880 (UMLS CUI [1,2])
ID.8
Item
allergy or sensitivity to metformin or similar drugs or any medical conditions which prohibit metformin use
boolean
C0571648 (UMLS CUI [1])
ID.9
Item
excessive blood donation 56 days before the start of the study
boolean
C0005794 (UMLS CUI [1])
ID.10
Item
urinary tract or bladder infections within four weeks of study start
boolean
C0042029 (UMLS CUI [1,1])
C0600041 (UMLS CUI [1,2])
ID.11
Item
alcohol abuse or illicit drug use within 12 months of study start
boolean
C0085762 (UMLS CUI [1,1])
C0086190 (UMLS CUI [1,2])
ID.12
Item
receiving other investigational drugs or participating in other research trials within 30 of the study start
boolean
C0013230 (UMLS CUI [1])
ID.13
Item
use of prescription or non-prescription drugs, including vitamins, herbal and dietary supplements with 7-14 days of study start
boolean
C0033081 (UMLS CUI [1,1])
C0013231 (UMLS CUI [1,2])
ID.14
Item
live alone without regular, daily interactions with someone who can be an emergency contact
boolean
C0260794 (UMLS CUI [1,1])
C1552023 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial